Jianmin FANG

Person

Yantai, CN

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-mesothelin antibody and antibody drug conjugate thereof
- Patent number 12,171,840
- Issue date Dec 24, 2024
- REMEGEN, LTD.
- Jianmin Fang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bifunctional angiogenesis inhibitor and use thereof
- Patent number 11,629,180
- Issue date Apr 18, 2023
- Remegen Co., Ltd.
- Jing Jiang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-HER2 antibody and conjugate thereof
- Patent number 10,087,260
- Issue date Oct 2, 2018
- REMEGEN, LTD.
- Jianmin Fang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
FGFR-FC fusion proteins and the use thereof
- Patent number 9,957,313
- Issue date May 1, 2018
- REMEGEN, LTD.
- Jianmin Fang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fusion protein for antagonizing angiogenesis inducible factors and...
- Patent number 9,522,949
- Issue date Dec 20, 2016
- YANTAI RC BIOTECHNOLOGIES, LTD.
- Jianmin Fang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
FGFR-Fc fusion proteins and the use thereof
- Patent number 9,273,137
- Issue date Mar 1, 2016
- REMEGEN, LTD.
- Jianmin Fang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
USE OF HER2-TARGETING ANTIBODY-DRUG CONJUGATE IN TREATMENT OF HER2-...
- Publication number 20240207424
- Publication date Jun 27, 2024
- RemeGen Co., Ltd.
- Jianmin FANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF ANTIBODY-DRUG CONJUGATE IN COMBINATION WITH IMMUNE CHECKPOIN...
- Publication number 20240207431
- Publication date Jun 27, 2024
- RemeGen Co., Ltd.
- Jianmin FANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-C-MET ANTIBODY-DRUG CONJUGATE AND APPLICATIONS THEREOF
- Publication number 20240165253
- Publication date May 23, 2024
- RemeGen Co., Ltd.
- Jianmin FANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF ANTIBODY-DRUG CONJUGATE TARGETING HER2 IN TREATMENT OF SPECI...
- Publication number 20240148894
- Publication date May 9, 2024
- RemeGen Co., Ltd.
- Jianmin FANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR TREATING SJOGREN'S SYNDROME USING TACI-FC FUSION PROTEIN
- Publication number 20240018212
- Publication date Jan 18, 2024
- RemeGen Co., Ltd.
- Jianmin FANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHOD FOR TREATING IGA NEPHROPATHY WITH TACI-FC FUSION PROTEIN
- Publication number 20240002468
- Publication date Jan 4, 2024
- REMEGEN CO., LTD.
- Jianmin FANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CLAUDIN 18.2 ANTIBODY AND ANTIBODY-DRUG CONJUGATE THEREOF
- Publication number 20230272109
- Publication date Aug 31, 2023
- RemeGen Co., Ltd.
- Jianmin FANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BISPECIFIC FUSION PROTEIN AND APPLICATION THEREOF
- Publication number 20220204626
- Publication date Jun 30, 2022
- REMEGEN CO., LTD.
- Jianmin Fang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI PD-L1 ANTIBODY AND USE THEREOF
- Publication number 20220177590
- Publication date Jun 9, 2022
- Remegen Co., Ltd.
- Jianmin FANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL TACI-FC FUSION PROTEIN FORMULATION
- Publication number 20220133633
- Publication date May 5, 2022
- Remegen Co., Ltd.
- Qiaoyu Xu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LINKER FOR ANTIBODY-DRUG CONJUGATES AND ITS USE
- Publication number 20220072137
- Publication date Mar 10, 2022
- RemeGen Co., Ltd.
- Changjiang Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-MESOTHELIN ANTIBODY AND ANTIBODY DRUG CONJUGATE THEREOF
- Publication number 20220056147
- Publication date Feb 24, 2022
- RemeGen, Ltd.
- Jianmin Fang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TACI-FC FUSION PROTEINS AND USES THEREOF
- Publication number 20220002381
- Publication date Jan 6, 2022
- REMEGEN CO., LTD.
- Jianmin Fang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL ANGIOGENESIS INHIBITOR AND USE THEREOF
- Publication number 20210324039
- Publication date Oct 21, 2021
- REMEGEN CO., LTD.
- Jing Jiang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY FOR HER2 CONCOMITANT DIAGNOSIS IMMUNOHISTOCHEMICAL DETECTI...
- Publication number 20210238305
- Publication date Aug 5, 2021
- REMEGEN CO., LTD.
- Zhanjiao YU
- G01 - MEASURING TESTING
Information Patent Application
PHARMACEUTICAL FORMULATIONS OF HER2 ANTIBODY-DRUG CONJUGATE
- Publication number 20210154314
- Publication date May 27, 2021
- Zhuanglin Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APPLICATION OF TACI-FC FUSION PROTEIN IN PREPARATION OF DRUGS FOR T...
- Publication number 20210087253
- Publication date Mar 25, 2021
- REMEGEN, LTD.
- Jianmin Fang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE IN TREATING UROTHELIAL CAR...
- Publication number 20200289663
- Publication date Sep 17, 2020
- RemeGen, Ltd.
- Jianmin FANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR PREPARING INTERMEDIATE OF ANTIBODY DRUG CONJUGATE
- Publication number 20200138968
- Publication date May 7, 2020
- RemeGen, Ltd.
- Changjiang HUANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FGFR-FC Fusion Proteins and the Use Thereof
- Publication number 20160347817
- Publication date Dec 1, 2016
- RemeGen, Ltd.
- Jianmin FANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-HER2 ANTIBODY AND CONJUGATE THEREOF
- Publication number 20160304621
- Publication date Oct 20, 2016
- REMEGEN, LTD.
- Jianmin FANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FGFR-FC Fusion Proteins and the Use Thereof
- Publication number 20160176945
- Publication date Jun 23, 2016
- Yantai RC Biotechnologies, LTD.
- Jianmin FANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FGFR-FC FUSION PROTEIN AND USE THEREOF
- Publication number 20130195864
- Publication date Aug 1, 2013
- YANTAI RC BIOTECHNOLOGIES
- JIANMIN FANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION PROTEIN FOR ANTAGONIZING ANGIOGENESIS INDUCIBLE FACTORS AND...
- Publication number 20130190235
- Publication date Jul 25, 2013
- YANTAI RC BIOTECHNOLOGIES
- JIANMIN FANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Jianmin FANG

Person

Patents Grantslast 30 patents

Anti-mesothelin antibody and antibody drug conjugate thereof

Bifunctional angiogenesis inhibitor and use thereof

Anti-HER2 antibody and conjugate thereof

FGFR-FC fusion proteins and the use thereof

Fusion protein for antagonizing angiogenesis inducible factors and...

FGFR-Fc fusion proteins and the use thereof

Patents Applicationslast 30 patents

USE OF HER2-TARGETING ANTIBODY-DRUG CONJUGATE IN TREATMENT OF HER2-...

USE OF ANTIBODY-DRUG CONJUGATE IN COMBINATION WITH IMMUNE CHECKPOIN...

ANTI-C-MET ANTIBODY-DRUG CONJUGATE AND APPLICATIONS THEREOF

USE OF ANTIBODY-DRUG CONJUGATE TARGETING HER2 IN TREATMENT OF SPECI...

METHOD FOR TREATING SJOGREN'S SYNDROME USING TACI-FC FUSION PROTEIN

METHOD FOR TREATING IGA NEPHROPATHY WITH TACI-FC FUSION PROTEIN

ANTI-CLAUDIN 18.2 ANTIBODY AND ANTIBODY-DRUG CONJUGATE THEREOF

BISPECIFIC FUSION PROTEIN AND APPLICATION THEREOF

ANTI PD-L1 ANTIBODY AND USE THEREOF

PHARMACEUTICAL TACI-FC FUSION PROTEIN FORMULATION

LINKER FOR ANTIBODY-DRUG CONJUGATES AND ITS USE

ANTI-MESOTHELIN ANTIBODY AND ANTIBODY DRUG CONJUGATE THEREOF

TACI-FC FUSION PROTEINS AND USES THEREOF

BIFUNCTIONAL ANGIOGENESIS INHIBITOR AND USE THEREOF

ANTIBODY FOR HER2 CONCOMITANT DIAGNOSIS IMMUNOHISTOCHEMICAL DETECTI...

PHARMACEUTICAL FORMULATIONS OF HER2 ANTIBODY-DRUG CONJUGATE

APPLICATION OF TACI-FC FUSION PROTEIN IN PREPARATION OF DRUGS FOR T...

USE OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE IN TREATING UROTHELIAL CAR...

PROCESS FOR PREPARING INTERMEDIATE OF ANTIBODY DRUG CONJUGATE

FGFR-FC Fusion Proteins and the Use Thereof

ANTI-HER2 ANTIBODY AND CONJUGATE THEREOF

FGFR-FC Fusion Proteins and the Use Thereof

FGFR-FC FUSION PROTEIN AND USE THEREOF

FUSION PROTEIN FOR ANTAGONIZING ANGIOGENESIS INDUCIBLE FACTORS AND...